ONCSM PEER ANALYSIS

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi — metric-by-metric comparison with peers and the industry median

ONCSMOncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi

🇹🇷 Turkey · IS · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

ONCSMIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ONCSM	MXCT	CVRX	SN	INGN	NNOX	Ind. Median
P/E	120.21	—	—	20.55●	—	—	26.49
P/B	13.12	0.81	4.77	2.48	0.97	0.64●	2.48
EV/EBITDA	25.01	—	—	9.87●	—	—	14.85
P/S	7.52	4.24	2.35	2.08	0.50●	5.59	2.56

Financial Health
Metric	ONCSM	MXCT	CVRX	SN	INGN	NNOX	Ind. Median
Current Ratio	2.25	12.04●	10.20	2.57	3.10	3.64	3.28
Debt/Equity	35.0%	10.4%	204.0%	62.9%	9.3%	6.0%●	44.7%
NetDebt/EBITDA	0.42	-0.08●	0.28	1.72	18.07	0.74	0.82

Profitability
Metric	ONCSM	MXCT	CVRX	SN	INGN	NNOX	Ind. Median
Net Margin	6.3%	-121.2%	-89.1%	10.1%●	-7.1%	-523.8%	-5.7%
ROE	12.9%●	-21.3%	-107.0%	12.1%	-13.1%	-50.1%	-8.6%
ROA	8.0%●	-18.4%	-45.9%	6.1%	-8.4%	-44.4%	-6.4%
EBITDA Margin	30.6%●	-107.3%	-77.8%	25.6%	-1.5%	-336.6%	5.2%

Growth + Dividend
Metric	ONCSM	MXCT	CVRX	SN	INGN	NNOX	Ind. Median
Rev. Growth	39.1%●	-14.3%	11.7%	—	3.4%	25.7%	7.4%
NI Growth	—	—	—	—	—	—	16.7%
Div. Yield	0.0%	—	—	3.5%●	—	—	1.1%
Payout	0.0%	—	—	52.8%	—	—	39.0%

Valuation
Metric	ONCSM	MEDTR	ANGEN	Ind. Median
P/E	120.21●	612.13	—	26.49
P/B	13.12	1.11●	1.34	2.48
EV/EBITDA	25.01	11.25●	35.20	14.85
P/S	7.52	1.21●	2.99	2.56

Financial Health
Metric	ONCSM	MEDTR	ANGEN	Ind. Median
Current Ratio	2.25	3.58●	2.31	3.28
Debt/Equity	35.0%	1.0%●	28.1%	44.7%
NetDebt/EBITDA	0.42	-1.64●	4.71	0.82

Profitability
Metric	ONCSM	MEDTR	ANGEN	Ind. Median
Net Margin	6.3%●	0.2%	-45.0%	-5.7%
ROE	12.9%●	0.2%	-21.0%	-8.6%
ROA	8.0%●	0.2%	-15.7%	-6.4%
EBITDA Margin	30.6%●	9.4%	9.8%	5.2%

Growth + Dividend
Metric	ONCSM	MEDTR	ANGEN	Ind. Median
Rev. Growth	39.1%●	6.5%	11.7%	7.4%
NI Growth	—	-62.9%	—	16.7%
Div. Yield	0.0%	1.1%●	0.0%	1.1%
Payout	0.0%	656.3%	0.0%	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ONCSM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.